Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
S-adenosyl-L-methionine + a 5'-(N7-methyl 5'-triphosphoguanosine)-(purine-ribonucleotide)-[mRNA]
S-adenosyl-L-homocysteine + a 5'-(N7-methyl 5'-triphosphoguanosine)-(2'-O-methyl-purine-ribonucleotide)-[mRNA]
-
-
-
?
S-adenosyl-L-methionine + a 5'-(N7-methyl 5'-triphosphoguanosine)-(purine-ribonucleotide)-[mRNA]
S-adenosyl-L-homocysteine + a 5'-(N7-methyl 5'-triphosphoguanosine)-(2'-O-methyl-purine-ribonucleotide)-[mRNA]
-
-
-
-
?
S-adenosyl-L-methionine + G(5')pppA-poly(A)
S-adenosyl-L-homocysteine + G(5')pppA-2'-OMe-poly(A)
-
-
-
-
r
S-adenosyl-L-methionine + m7G(5')pppA-poly(A)
S-adenosyl-L-homocysteine + m7G(5')pppA-2'-OMe-poly(A)
-
-
-
-
r
S-adenosyl-L-methionine + m7G(5')pppG-RNA
S-adenosyl-L-homocysteine + m7G(5')pppGm-RNA
-
cap1 formation is optimal at 0.005 mM S-adenosyl-L-methionine
-
-
?
S-adenosyl-L-methionine + m7G(5')pppNmpN-RNA
S-adenosyl-L-homocysteine + m7G(5')pppNmpNm-RNA
-
N: purin and pyrimidine nucleotides are methylated, enzyme: cap II-methyltransferase
i.e. cap II
?
S-adenosyl-L-methionine + m7G(5')pppNpN-RNA
S-adenosyl-L-homocysteine + m7G(5')pppNmpN-RNA
-
i.e. cap O, N: purine and pyrimidine nucleotides are methylated, enzyme: cap I-methyltransferase, substrates are RNAs with a capped terminus with at least 2 additional nucleotides, G(5')pppNpNp
i.e. cap I
?
S-adenosyl-L-methionine + m7G(5')pppR-RNA
S-adenosyl-L-homocysteine + m7G(5')pppRm-RNA
S-adenosyl-L-methionine + m7GpppApGp
S-adenosyl-L-homocysteine + m7GpppAmpGp
-
i.e. capped dinucleotide, cap I-methyltransferase
-
?
S-adenosyl-L-methionine + m7GpppApGpUp
S-adenosyl-L-homocysteine + m7GpppAmpGpUp
-
i.e. capped trinucleotide, cap I-methyltransferase
-
?
S-adenosyl-L-methionine + mononucleotide
?
-
such as m7GpppA or GpppA, poor substrates for cap I-methyltransferase
-
-
?
additional information
?
-
-
the enzyme catalyzes specific methylation of the 2'-O-ribose of the first nucleotide of a capped RNA transcript
-
-
?
S-adenosyl-L-methionine + m7G(5')pppR-RNA
S-adenosyl-L-homocysteine + m7G(5')pppRm-RNA
-
satellite tobacco necrosis virus
-
-
?
S-adenosyl-L-methionine + m7G(5')pppR-RNA
S-adenosyl-L-homocysteine + m7G(5')pppRm-RNA
-
unmethylated vaccinia virus mRNA
-
-
?
S-adenosyl-L-methionine + m7G(5')pppR-RNA
S-adenosyl-L-homocysteine + m7G(5')pppRm-RNA
-
unmethylated vaccinia virus mRNA
mRNA containing a 2'-O-methylpurine cap, R may be guanine or adenosine, prereplicative viral product
?
S-adenosyl-L-methionine + m7G(5')pppR-RNA
S-adenosyl-L-homocysteine + m7G(5')pppRm-RNA
-
best substrates are poly(A)-nucleosides and poly-(I)-nucleosides with m7G(5')pppN-ends
-
-
?
S-adenosyl-L-methionine + m7G(5')pppR-RNA
S-adenosyl-L-homocysteine + m7G(5')pppRm-RNA
-
specific, in vitro methyl group acceptors are polyribonucleosides containing 7-methylguanine(5')pppG-terminals
mRNA containing a 2'-O-methylpurine cap, R may be guanine or adenosine, prereplicative viral product
?
S-adenosyl-L-methionine + m7G(5')pppR-RNA
S-adenosyl-L-homocysteine + m7G(5')pppRm-RNA
-
brome mosaic virus RNA ending in m7G(5')pppG as substrate
mRNA containing a 2'-O-methylpurine cap, R may be guanine or adenosine, prereplicative viral product
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Acquired Immunodeficiency Syndrome
1H, 13C, and 15N backbone chemical shift assignments of coronavirus-2 non-structural protein Nsp10.
Arteritis
Arterivirus nsp12 versus the coronavirus nsp16 2'-O-methyltransferase: comparison of the C-terminal cleavage products of two nidovirus pp1ab polyproteins.
Asthma
CMTR1 is associated with increased asthma exacerbations in patients taking inhaled corticosteroids.
Carcinoma, Ehrlich Tumor
Isolation and characterization of a nucleolar 2'-O-methyltransferase from Ehrlich ascites tumor cells.
Carcinoma, Ehrlich Tumor
Specificity of a nucleolar 2'-O-methyltransferase for RNA substrates.
Coronavirus Infections
Binding of the Methyl Donor
Coronavirus Infections
Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis.
COVID-19
Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study.
COVID-19
In silico identification of novel SARS-COV-2 2'-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches.
COVID-19
Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.
COVID-19
SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
COVID-19
Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2'-O-Methyltransferase.
COVID-19
Whole Genome Sequencing of SARS-CoV-2 Strains in COVID-19 Patients From Djibouti Shows Novel Mutations and Clades Replacing Over Time.
Dengue
A structural basis for the inhibition of the NS5 dengue virus mRNA 2'-O-methyltransferase domain by ribavirin 5'-triphosphate.
Dengue
Biochemical characterization of the (nucleoside-2'O)-methyltransferase activity of dengue virus protein NS5 using purified capped RNA oligonucleotides 7MeGpppACn and GpppACn.
Dengue
Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants.
Dengue
Correction: Rational Design of a Live Attenuated Dengue Vaccine: 2'-O-Methyltransferase Mutants Are Highly Attenuated and Immunogenic in Mice and Macaques.
Dengue
Designing cyclopentapeptide inhibitor as potential antiviral drug for dengue virus ns5 methyltransferase.
Dengue
Evaluation of Adamantane Derivatives as Inhibitors of Dengue Virus mRNA Cap Methyltransferase by Docking and Molecular Dynamics Simulations.
Dengue
High-yield production of short GpppA- and 7MeGpppA-capped RNAs and HPLC-monitoring of methyltransfer reactions at the guanine-N7 and adenosine-2'O positions.
Dengue
Higher catalytic efficiency of N-7-methylation is responsible for processive N-7 and 2'-O methyltransferase activity in dengue virus.
Dengue
Inhibition of dengue viral infection by diasarone-I is associated with 2'O methyltransferase of NS5.
Dengue
Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques.
Encephalitis, Japanese
Ifit1 Inhibits Japanese Encephalitis Virus Replication through Binding to 5' Capped 2'-O Unmethylated RNA.
Hepatitis
Construction and genetic analysis of murine hepatitis virus strain A59 Nsp16 temperature sensitive mutant and the revertant virus.
Hepatitis
Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.
Infections
Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.
Infections
Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments.
Infections
Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.
Influenza, Human
Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection.
Intellectual Disability
Loss of Ftsj1 perturbs codon-specific translation efficiency in the brain and is associated with X-linked intellectual disability.
Neoplasms
Isolation and characterization of a nucleolar 2'-O-methyltransferase from Ehrlich ascites tumor cells.
Neoplasms
Specificity of a nucleolar 2'-O-methyltransferase for RNA substrates.
Severe Acute Respiratory Syndrome
Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.
Severe Acute Respiratory Syndrome
Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.
Severe Acute Respiratory Syndrome
Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 complex.
Severe Acute Respiratory Syndrome
Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10.
Severe Acute Respiratory Syndrome
Molecular mapping of the RNA Cap 2'-O-methyltransferase activation interface between severe acute respiratory syndrome coronavirus nsp10 and nsp16.
Severe Acute Respiratory Syndrome
Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.
Vaccinia
A polyadenylylation-specific RNA-contact site on the surface of the bifunctional vaccinia virus RNA modifying protein VP39 that is distinct from the mRNA 5' end-binding "cleft".
Vaccinia
A protein related to the vaccinia virus cap-specific methyltransferase VP39 is involved in cap 4 modification in Trypanosoma brucei.
Vaccinia
Active site in RrmJ, a heat shock-induced methyltransferase.
Vaccinia
Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity.
Vaccinia
Genetic Analysis of Murine Hepatitis Virus Non-Structural Protein 16.
Vaccinia
Insertion of an N7-methylguanine mRNA cap between two coplanar aromatic residues of a cap-binding protein is fast and selective for a positively charged cap.
Vaccinia
Interaction between the J3R subunit of vaccinia virus poly(A) polymerase and the H4L subunit of the viral RNA polymerase.
Vaccinia
Mechanism of RNA 2'-O-methylation: evidence that the catalytic lysine acts to steer rather than deprotonate the target nucleophile.
Vaccinia
Methyltransferase-specific domains within VP-39, a bifunctional protein that participates in the modification of both mRNA ends.
Vaccinia
Mutational analysis of a multifunctional protein, with mRNA 5' cap-specific (nucleoside-2'-O-)-methyltransferase and 3'-adenylyltransferase stimulatory activities, encoded by vaccinia virus.
Vaccinia
pK(a) of the mRNA Cap-Specific 2'-O-Methyltransferase Catalytic Lysine by HSQC NMR Detection of a Two-Carbon Probe.
Vaccinia
Recognition of capped RNA substrates by VP39, the vaccinia virus-encoded mRNA cap-specific 2'-O-methyltransferase.
Vaccinia
Studying vaccinia virus RNA processing in vitro.
Vaccinia
The 1.85 A structure of vaccinia protein VP39: a bifunctional enzyme that participates in the modification of both mRNA ends.
Vaccinia
The vaccinia virus bifunctional gene J3 (nucleoside-2'-O-)-methyltransferase and poly(A) polymerase stimulatory factor is implicated as a positive transcription elongation factor by two genetic approaches.
Vaccinia
Transcription elongation activity of the vaccinia virus J3 protein in vivo is independent of poly(A) polymerase stimulation.
Vesicular Stomatitis
Identification of sendai virus L protein amino acid residues affecting viral mRNA cap methylation.
Vesicular Stomatitis
Sequence-function analysis of the Sendai virus L protein domain VI.
Virus Diseases
Emetine, a potent alkaloid for the treatment of SARS-CoV-2 targeting papain-like protease and non-structural proteins: pharmacokinetics, molecular docking and dynamic studies.
Virus Diseases
Inhibition of dengue viral infection by diasarone-I is associated with 2'O methyltransferase of NS5.
Virus Diseases
The human interferon-regulated ISG95 protein interacts with RNA polymerase II and shows methyltransferase activity.
Virus Diseases
The mRNA Cap 2'-O-Methyltransferase CMTR1 Regulates the Expression of Certain Interferon-Stimulated Genes.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Langberg, S.R.; Moss, B.
Post-transcriptional modifications of mRNA. Purification and characterization of cap I and cap II RNA (nucleoside-2-)-methyltransferases from HeLa cells
J. Biol. Chem.
256
10054-10060
1981
Homo sapiens
brenda
Boone, R.F.; Ensinger, M.J.; Moss, B.
Synthesis of mRNA guanylyltransferase and mRNA methyltransferases in cells infected with vaccinia virus
J. Virol.
21
475-483
1977
Homo sapiens
brenda
Belanger, F.; Stepinski, J.; Darzynkiewicz, E.; Pelletier, J.
Characterization of hMTr1, a human Cap1 2-O-ribose methyltransferase
J. Biol. Chem.
285
33037-33044
2010
Homo sapiens
brenda
Simabuco, F.M.; Pavan, I.C.B.; Pestana, N.F.; Carvalho, P.C.; Basei, F.L.; Campos Granato, D.; Paes Leme, A.F.; Zanchin, N.I.T.
Interactome analysis of the human cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (hMTr1) protein
J. Cell. Biochem.
120
5597-5611
2019
Homo sapiens (Q8N1G2), Homo sapiens
brenda
Toczydlowska-Socha, D.; Zielinska, M.M.; Kurkowska, M.; Astha, M.; Almeida, C.F.; Stefaniak, F.; Purta, E.; Bujnicki, J.M.
Human RNA cap1 methyltransferase CMTr1 cooperates with RNA helicase DHX15 to modify RNAs with highly structured 5 termini
Philos. Trans. R. Soc. Lond. B Biol. Sci.
373
20180161
2018
Homo sapiens
brenda